Skip to main navigation
Logo

Investors

Press Releases

Press Releases

  • All
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2016
July 31, 2024
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 8, 2024
Adicet Bio Receives FDA Fast Track Designation for ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
June 28, 2024
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 24, 2024
Adicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell Carcinoma
June 5, 2024
Adicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus Nephritis
May 31, 2024
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 29, 2024
Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference
May 14, 2024
Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates
May 14, 2024
Adicet Bio Announces Poster Presentation of ADI-270 Preclinical Data at the 2024 European Hematology Association (EHA) Hybrid Congress
May 7, 2024
Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page next ›
  • Last page last »
Displaying 21 - 30 of 163

Tools

  • Print
    Print
  • Email Alerts
    Email Alerts
  • Investor Contacts
    Investor Contacts

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
  • Stock Information
  • Corporate Governance
  • Financial Information
  • Investor Resources

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
    • Stock Quote & Chart
    • Analyst Coverage
    • Governance Highlights
    • Leadership and Board of Directiors
  • Financial Information
    • Investor FAQs
    • Information Request
    • Email Alerts
    • Investor Contacts

Adicet - Header Navigation

  • About
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Gamma Delta T Cells
    • Targeting Moieties
    • Proprietary Cell Platform
  • Pipeline
    • Pipeline
    • Expanded Access Policy
    • Presentations and Publications
  • Investors
    • Overview
    • Press Releases
    • Presentations & Events
    • Stock Information
    • Corporate Governance
    • Financial Information
    • Investor Resources
  • Careers
    • Join Our Team
    • Current Openings
  • Contact

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Governance Highlights
    • Leadership and Board of Directiors
  • Financial Information
  • Investor Resources
    • Investor FAQs
    • Information Request
    • Email Alerts
    • Investor Contacts
Logo © 2024 Adicet Bio All rights reserved. Website Design: Hane Chow, Inc.